
6.61 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 3.68 Today|||52-Week Range 9.65 | -22.51% Year-to-Date |
The 3 analysts offering 12-month price forecasts for ARS Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 19.00 and a low estimate of 14.00. The median estimate represents a +157.19% increase from the last price of 6.61.
The current consensus among 3 polled investment analysts is to Buy stock in ARS Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.